Skip to content

Evaluation of the effect of medications administration associated factors on depression and anxiety of hospitalized patients in infectious ward

Evaluation of the effect of medications administration associated factors on depression and anxiety of hospitalized patients in infectious ward

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201404216026N2
Enrollment
120
Registered
2014-04-23
Start date
2013-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Anxiety. Condition 2: Depression. Anxiety disorder, unspecified Depressive episode, unspecified

Interventions

Intervention 1: Intervention group: The presence of clinical pharmacist and her effect of pharmacotherapy. Intervention 2: Control group: Absence of clinical pharmacist.
Treatment - Other
Intervention group: The presence of clinical pharmacist and her effect of pharmacotherapy
Control group: Absence of clinical pharmacist

Sponsors

Kerman university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age ranged 16-55 years old; be conscious; do not have any psychiatric disorder. Exclusion criteria: do not have any chronic disease such as cancer, HIV or COPD that cause depression.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Depression. Timepoint: second or third day of hospitalization. Method of measurement: hospital anxiety and depression scale.;Anxiety. Timepoint: second or third day of hospitalization. Method of measurement: hospital anxiety and depression scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Dabaghzadeh

Kerman University of Medical Sciences

fatemeh_dabaghzadeh@yahoo.com+98 34 1320 5034

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026